These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Direct evidence for a position input to the smooth pursuit system. Blohm G; Missal M; Lefèvre P J Neurophysiol; 2005 Jul; 94(1):712-21. PubMed ID: 15728771 [TBL] [Abstract][Full Text] [Related]
44. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up. de Haan L; van Amelsvoort T; Dingemans P; Linszen D Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650 [TBL] [Abstract][Full Text] [Related]
46. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
47. Smooth pursuit eye tracking over a structured background in first-episode schizophrenic patients. Hutton SB; Crawford TJ; Kennard C; Barnes TR; Joyce EM Eur Arch Psychiatry Clin Neurosci; 2000; 250(5):221-5. PubMed ID: 11097164 [TBL] [Abstract][Full Text] [Related]
48. Increased saccadic rate during smooth pursuit eye movements in patients at Ultra High Risk for developing a psychosis. van Tricht MJ; Nieman DH; Bour LJ; Boerée T; Koelman JH; de Haan L; Linszen DH Brain Cogn; 2010 Aug; 73(3):215-21. PubMed ID: 20538400 [TBL] [Abstract][Full Text] [Related]
49. Relationship between smooth pursuit eye-tracking and cognitive performance in schizophrenia. Friedman L; Kenny JT; Jesberger JA; Choy MM; Meltzer HY Biol Psychiatry; 1995 Feb; 37(4):265-72. PubMed ID: 7711164 [TBL] [Abstract][Full Text] [Related]
50. A developmental study of smooth pursuit eye movements in normal children from 7 to 15 years of age. Ross RG; Radant AD; Hommer DW J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):783-91. PubMed ID: 8340299 [TBL] [Abstract][Full Text] [Related]
51. Eye tracking abnormalities in schizophrenia: evidence for dysfunction in the frontal eye fields. Sweeney JA; Luna B; Srinivasagam NM; Keshavan MS; Schooler NR; Haas GL; Carl JR Biol Psychiatry; 1998 Oct; 44(8):698-708. PubMed ID: 9798073 [TBL] [Abstract][Full Text] [Related]
52. Ethanol impairs saccadic and smooth pursuit eye movements without producing self-reports of sedation. Holdstock L; de Wit H Alcohol Clin Exp Res; 1999 Apr; 23(4):664-72. PubMed ID: 10235302 [TBL] [Abstract][Full Text] [Related]
53. [Selective attention and schizophrenia before the administration of neuroleptics]. Lussier I; Stip E Encephale; 1999; 25(6):576-83. PubMed ID: 10668600 [TBL] [Abstract][Full Text] [Related]
54. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment. Wyatt RJ; Damiani LM; Henter ID Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131 [TBL] [Abstract][Full Text] [Related]
55. Eye movements in schizophrenia: a quantitative analysis. Cegalis JA; Sweeney JA Biol Psychiatry; 1979 Feb; 14(1):13-26. PubMed ID: 420896 [TBL] [Abstract][Full Text] [Related]
56. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate]. Roncoroni D Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121 [TBL] [Abstract][Full Text] [Related]
57. Smooth pursuit eye movements in schizophrenia: influences of neuroleptic treatment and the question of specificity. Küfferle B; Friedmann A; Topitz A; Földes P; Anderer P; Kutzer M; Steinberger K Psychopathology; 1990; 23(2):106-14. PubMed ID: 1979684 [TBL] [Abstract][Full Text] [Related]
58. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Olincy A; Ross RG; Young DA; Roath M; Freedman R Neuropsychopharmacology; 1998 Mar; 18(3):175-85. PubMed ID: 9471115 [TBL] [Abstract][Full Text] [Related]
59. Eye tracking performance and the boundaries of the schizophrenia spectrum. Mitropoulou V; Friedman L; Zegarelli G; Wajnberg S; Meshberg J; Silverman JM; Siever LJ Psychiatry Res; 2011 Mar; 186(1):18-22. PubMed ID: 20826004 [TBL] [Abstract][Full Text] [Related]
60. SPEM impairment in drug-naive schizophrenic patients: evidence for a trait marker. Campion D; Thibaut F; Denise P; Courtin P; Pottier M; Levillain D Biol Psychiatry; 1992 Nov; 32(10):891-902. PubMed ID: 1361365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]